Image guided cryoablation for malignant bone and soft tissue tumor

Image guided cryoablation for malignant bone and soft tissue tumor - Cryoablation for malignant bone and soft tissue tumor

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016044

Enrollment

Registered

2014-12-26

Start date

2011-08-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent or metastatic bone and soft tissue tumors

Interventions

Recurrent or metastatic bone and soft tissue tumor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Recurrent or metastatic bone and soft tissue tumor

Exclusion criteria

Exclusion criteria: 1. Cases with coagulation disorder or hemorrhagic tendency. 2. Lesions that are adjacent to vital organs. 3. Cases with systemic or local infection near the treatment site.

Design outcomes

Primary

Measure	Time frame
Effectiveness against the tumor will be analyzed at 1 month after treatment and every 3 month afterward using Xp, CT, and MRI. Pain will be assessed prior to the treatment, 1 day and 1 week after the treatment, and every 3 month afterward using the VAS.	—

Countries

Japan

Contacts

Public ContactHideo Morioka

Keio University School of Medicine Department of orthopaedic surgery

morioka@z3.keio.jp03-5363-3812

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026